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Abstract
The unique DNA-binding properties of distinct NF-κB dimers are known to influence the
selective regulation of NF-κB target genes. To gain a stronger appreciation for these dimer-
specific differences, we have combined protein-binding microarrays (PBM) and surface plasmon
resonance (SPR) to evaluate DNA sites recognized by eight different NF-κB dimers. We observed
three distinct binding-specificity classes and provide insight into mechanisms by which dimers
might regulate distinct sets of genes. We identified many new non-traditional κB site sequences
and highlight an under-appreciated plasticity of NF-κB dimers in recognizing κB sites with a
single consensus half-site. This study provides a database that will be of broad utility in efforts to
identify NF-κB target sites and uncover gene regulatory circuitry.
Introduction
The transcription factor NF-κB regulates a broad range of genes central to the body’s
immune and inflammatory responses1-4. NF-κB represents homo- and heterodimers of five
different family members: c-Rel (REL), RelA/p65 (RELA), RelB (RELB), p50/p105
(NFKB1), and p52/p100 (NFKB2)5-7. Studies of knockout mice have revealed that each NF-
κB family member carries out unique biological functions8-11. At a molecular level, DNA-
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binding differences of individual NF-κB dimers have been linked to dimer-specific roles in
gene regulation6,7; however, much remains unclear regarding the full scope of these
differences and how they affect dimer-specific functions in vivo.
Protein-DNA crystal structures6,12 and DNA-binding studies12-14 have led to a basic
partition of the NF-κB family members: p50 and p52 recognize a 5-bp 5′-GGGRN-3′ half-
site, while c-Rel, RelA, and RelB recognize a 4-bp 5′-GGRR-3′ half-site (R = {A,G};
N={A,C,G,T}). These half-sites, separated by a 1-bp spacer, led to the consensus
heterodimer binding site (i.e., κB site) 5′-GGGRN(Y)YYCC-3′15. Despite the appeal of
this paradigm, reports of additional dimer-specific DNA-binding preferences16 and non-
canonical NF-κB binding site sequences5,17 suggest complications to this simple picture.
Dimer-specific DNA recognition provides a mechanism to disentangle the in vivo functions
of NF-κB heterodimers and closely related homodimers. One such example is specific
recognition of the murine BLC-κB site reported for the RelB:p52 heterodimer – the primary
dimer mediating the alternative NF-κB signaling pathway16,18-20. However, contradictory
results for RelB:p52-specific binding have been reported21. Binding of other NF-κB dimers
to non-canonical binding site sequences has also been reported and suggests plasticity in
DNA binding. Examples include the c-Rel target site in the Il12b gene promoter (5′-
GGGGAATTTT-3′)17 and the CD28 response element (CD28RE) from the Il2 and Csf2
gene promoters (5′-GGAATTTCT-3′)5. Both sites deviate from the consensus sequence and
score poorly according to the standard position weight matrices (PWMs) derived from
binding site selections13. Structural analyses of NF-κB dimers in complex with different κB
site sequences have also demonstrated a striking plasticity in the amino acid-base
interactions12. Together, these observations suggest that the consensus sequence and PWM
descriptions of NF-κB DNA binding are too limited.
To address these issues, we have used the protein-binding microarray (PBM)
technology22-24 and surface plasmon resonance (SPR) to perform an unbiased
characterization of potential κB binding site sequences using multiple NF-κB dimers.
Previous large-scale analyses of NF-κB DNA-binding have been biased either to certain κB
site sequences14,25 or to only the few highest affinity sites13. We observed three distinct NF-
kB binding-specificity classes, identified many new non-traditional κB site sequences, and
highlight an under-appreciated plasticity of NF-κB dimer binding for shorter kB sites with
one consensus half-site. We provide a novel and rich dataset and anticipate that it will prove
useful for genomic analysis of NF-κB regulatory elements and the interpretation of in vivo
binding experiments. The dataset plus online tools with DNA sequence search capabilities
are provided online (http://thebrain.bwh.harvard.edu/nfkb).
Results
Designing an NF-κB-specific protein-binding microarray
To examine the DNA-binding specificities of NF-κB dimers in a systematic and unbiased
manner, we utilized PBM technology. PBMs are double-stranded DNA microarrays that
allow the in vitro characterization of protein binding to tens of thousands of unique DNA
sequences in a single experiment24,26,27. The universal PBM (uPBM) developed
previously23 allows a comprehensive, unbiased assessment of protein-DNA binding to all
ungapped and gapped 8-bp sequences. We carried out uPBM experiments with six human
and mouse NF-κB dimers (c-Rel:c-Rel, RelA:RelA, p52:p52, p50:p50, c-Rel:p50,
RelB:p52) to perform an initial, comprehensive survey of potential κB site sequences. DNA
binding site motifs derived from the uPBM experiments were in excellent agreement with
published SELEX data on cRel:cRel, RelA:RelA and p50:p50 homodimers13
(Supplementary Fig. 1), demonstrating highly specific binding in our assay.
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The uPBM platform assesses binding to 8-bp sequences; however, the canonical NF-κB
binding site (κB site) is 10-bp long6,7. Therefore, we created a custom NF-κB PBM
containing 10-bp sequences prioritized according to the uPBM 8-bp data (see
Supplementary Methods). We compiled the 1,000 top-scoring 10-bp sequences determined
for the six NF-κB dimers into a list of 3,285 non-redundant sequences that represent the top-
scoring set of potential κB site sequences. These 10-bp κB sites were incorporated into a
custom NF-κB PBM with each site situated within constant flanking sequence (Fig. 1a, see
Methods).
We initially examined the binding of RelA:p50 to our custom NF-κB PBM. To assess
significance of the results, the natural log of the median PBM signal intensity of each 10-bp
site was transformed into a z-score using the scores from 1,200 randomly chosen 10-bp sites
as a background distribution (Fig. 1b; see Methods). Many potential κB sites, including a set
of validated κB sites, scored significantly higher than the background distribution (z-score >
4), demonstrating that the custom PBMs reveal the specific DNA binding sites of NF-κB
dimers. Thus, our custom NF-κB PBM provides a unique platform to assess the DNA-
binding specificities of different NF-κB dimers for a large set of potential κB site sequences.
Three distinct DNA binding classes
To examine the DNA-binding preferences of different NF-κB dimers, we performed custom
NF-κB PBM experiments for ten dimers from mouse or human. We compared the DNA-
binding specificities of different dimers by correlating their κB site z-scores. Hierarchical
clustering revealed that the NF-κB dimers separated into three distinct classes: p50 or p52
homodimers; heterodimers; and c-Rel or RelA homodimers (Fig. 1c). This subdivision is
similar to the basic division of the NF-κB family members into two subclasses based on
protein sequence of the Rel-homology domains: p50 and p52 (subclass 1); c-Rel, RelB and
RelA (subclass 2). The common binding specificity observed for the heterodimers suggests a
canonical DNA-binding contribution from members of each NF-κB subclass.
To highlight the differences between these three NF-κB classes, we constructed a
representative DNA binding site motif for each class (Fig. 1d; Supplementary Fig. 2 for all
individual motifs). We identified different DNA binding site motif lengths for each class: 9-
bp for c-Rel and RelA homodimers; 10-bp for heterodimers; 11- or 12-bp for p50 and p52
homodimers. We note that while our custom NF-κB PBM was designed to assay binding to
a large collection of 10-bp sequences, our de novo motif finding approach arrived at a longer
motif for p50 and p52 homodimers; length preferences are examined more directly below.
The 10-bp motif for the heterodimer class is in excellent agreement with the known NF-κB
consensus sequence 5′-GGGRNWYYCC-3′, demonstrating that we correctly identified the
known high-affinity binding sites. The variant 9-bp and 11-bp motifs for the c-Rel,RelA and
p50,p52 homodimer classes, respectively, also agree with the reported DNA-binding
preferences of these different homodimers6. A comprehensive overview of the binding
landscape for all dimers to the 10-bp κB sites is provided (Supplementary Fig. 3a), along
with example genomic regions in which our PBM data are used to annotate dimer
preferences for putative κB sites (Supplementary Fig. 3b,c).
In our pair-wise comparisons, all heterodimers exhibit a common DNA-binding specificity.
Of particular interest was our observation that RelB-containing heterodimers exhibit DNA-
binding specificity similar to that of c-Rel- and RelA-containing heterodimers. The
biological significance of this finding is discussed below (see Discussion).
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Dimer preferences for traditional and non-traditional κB sites
Dimer-specific DNA-binding preferences provide a mechanism for NF-κB dimers to target
distinct binding sites, and thus to regulate distinct target genes. We observed the most
distinct DNA-binding preferences (the lowest z-score correlation) between members of the
two homodimer classes (Fig. 1c). To investigate these differences further, we compared the
binding specificities of the most dissimilar dimers: p50:p50 and c-Rel:c-Rel (z-score
correlation = −0.13) (Fig. 2a). We observed many off-diagonal features that correspond to
sites bound preferentially by one of the dimers (’dimer-preferred’ κB sites).
To identify sequence features that could explain the relative dimer preferences, we examined
the c-Rel:c-Rel-preferred κB sites (κB sites with p50:p50 z-score < 2 and c-Rel:c-Rel z-
score > 4). We found that a majority had a strong 5′-HGGAA-3′ half-site (Fig. 2a, red
dots). Many of these sequences conform to the canonical c-Rel,RelA-preferred 9-bp binding
site with two 5′-HGGAA-3′ half-sites separated by a 1-bp spacer12,28. However, we also
found many non-traditional κB site sequences with only one 5′-HGGAA-3′ half-site. We
use the term “non-traditional” in lieu of “non-canonical” to avoid potential confusion with
variant κB sites (referred to as non-canonical) reported to be downstream of the non-
canonical NF-κB signaling pathway16. Non-traditional sites are defined as sites that score
poorly by the widely used NF-κB PWMs13,29 (see Supplementary Methods); examples
include CD28RE from the Il2 and Csf2 gene promoters (5′-GGAATTTCT-3′, c-Rel:c-Rel
z-score = 8.5) and the κB site from the murine Plau gene promoter (5′-GGAAAGTAC-3′,
c-Rel:c-Rel z-score = 12.9)5. We also found that a motif constructed from the c-Rel:c-Rel-
preferred κB sequences exhibited a strongly degenerate half-site (Fig. 2b). Therefore, while
the highest scoring c-Rel:c-Rel-preferred sites are pseudo-symmetric (Fig. 1d), a large
number of non-traditional, c-Rel:c-Rel-preferred sites (and RelA:RelA-preferred,
Supplementary Fig. 4) scored significantly above background yet have only a single
canonical 5′-HGGAA-3′ half-site.
Examining the p50:p50-preferred κB sites (p50:p50 z-score > 4, c-Rel:c-Rel z-score < 2),
we found a number of κB sites with a G-rich 5′ half-site. Highlighting the κB sites that
conform to the pattern 5′-GGGGGNNNNN-3′ (Fig. 2a, yellow dots), we observed a strong
p50:p50 preference, although a subset of the sites is also bound well by c-Rel:c-Rel
(discussed further below). A motif constructed from the G-rich sites bound well by p50:p50
(z-score > 4) exhibits a 5′-GGGGG-3′ half-site and a degenerate 3′ half-site (Fig. 2b),
although a moderate preference for adenine and thymine bases 3′ to the G-run was
observed. Therefore, similar to the c-Rel:c-Rel-preferred sites, we observed statistically
significant binding to a large group of κB sites defined by a single half-site sequence.
To ensure that the observed dimer-specific binding to non-traditional κB sites is not an
artifact of our PBM approach, we examined binding to a set of traditional and non-
traditional κB sites using SPR (Figs. 2b-d, Supplementary Fig. 5). Due to the very fast on-
rates (Kon) of some dimers, we were unable to obtain reliable Kon measurements. However,
we were able to obtain reliable off-rate (Koff) values and found excellent agreement between
the SPR-determined Koff values and our PBM-determined z-scores (Figs. 2d,e). These
results are consistent with previous reports25 showing differential off-rates as the major
contributor to binding affinity differences between κB sites. Our data demonstrate that our
PBM-determined z-scores reflect equilibrium binding measurements and lend further
support for the potential regulatory significance of the numerous non-traditional κB sites in
our dataset.
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Dimer preferences for κB sites of different lengths
DNA binding studies13 and X-ray crystal structures6,12 have revealed different κB site
lengths for c-Rel,RelA homodimers (9 bp), heterodimers (10 bp), and p50,p52 homodimers
(11 bp). These length preferences are consistent with the DNA binding site motifs we
determined for each dimer class (Fig. 1a). However, in light of the number of non-traditional
binding sites in our dataset, we sought to determine whether binding site length preferences
depend on the binding site sequence itself.
We examined how the DNA bases flanking 10-bp κB sites affect the binding to different
dimers. Since p50:p50 binds an 11-bp site, we expected to observe a strong effect due to
flanking base identity. We measured binding by PBM experiment to all 16 κB site variants
in which the bases immediately 5′ and 3′ to the 10-bp site were exhaustively sampled (Fig.
3a). Examining the binding of p50:p50, RelA:p50 and c-Rel:c-Rel to traditional κB site
sequences, we observed improved binding by p50:p50 and RelA:p50 with the addition of 5′
guanine to one strand (Fig. 3a, columns 1 and 2). These differences are readily understood in
terms of the known half-site preferences, with high-affinity binding occurring on 11-bp sites
with symmetrically opposed, optimal 5-bp half-sites: 5′-GGGGA(A)TCCCC-3′ and 5′-
GGGAA(A)TTCCC-3′. However, for p50:p50 the highest-affinity binding occurred with 5′
guanines flanking both half-sites, demonstrating a preference beyond the 5-bp half-site and
showing that a 12-bp site can be differentiated from an 11-bp site.
In contrast, we observed that binding of all three dimers was unaffected by the identity of
the bases flanking non-traditional κB sites (Fig. 3a, columns 3 and 4). This suggested a
different mode of protein-DNA interaction for non-traditional κB sites. To delimit their
lengths, we used our PBM dataset to examine binding to shorter κB sites. For example, to
interrogate binding to a 9-bp sub-sequence of the 5′-GGGGAATTTT-3′ site, we examined
binding to the four κB sites in our dataset of the form 5′-NGGGAATTTT-3′. Binding of
p50:p50 and RelA:p50 was insensitive to base identity at position 5 (positions numbered as
5′-G
-5G-4G-3A-2A-1T+1T+2T+3T+4T+5-3′) and only moderately sensitive to the base identity
at position −5 (Fig. 3b). Therefore, the length of this non-traditional site is 8 to 9 bp (5′-
gGGGAATTT-3′), which differs considerably from the 9- to 11-bp traditional κB site
sequences (Fig. 3a). In contrast, c-Rel:c-Rel binding is insensitive to positions −5 and −4,
but sensitive to base identity at position 5, demonstrating a similarly short 8-bp length but to
a different sub-sequence (5′-GGAATTTT-3′). The same preferences were observed for the
5′-GGGGGTTTTT-3′ site (Supplementary Fig. 6). Our data suggest that a fundamentally
different mode of binding mediates the recognition of traditional versus non-traditional sites
and that this translates into κB sites of different lengths. Furthermore, we observed that the
length of the binding site is dimer-specific.
We analyzed the role of flanking bases to 17 additional κB sites and similarly found that 5′
guanine bases were the most predictive of increased binding affinity for all NF-κB dimers,
and that the effect of a 5′ guanine was dependent on the G-content in adjacent bases. We
generated a linear model to predict the PBM scores for all 12-bp κB sites based on our set of
10-bp κB sites (see Supplementary Methods). We demonstrate the efficacy of this extended
dataset below in our comparison of PBM data with chromatin immunoprecipitation (ChIP)
data, and make the full dataset available for use in genomic analysis (see Supplementary
Data).
Affinity versus specificity of c-Rel and RelA homodimers
The Rel homology regions (RHRs) of c-Rel and RelA are more similar to each other than
are the RHRs of any other pair of NF-κB family members30. In vitro DNA-binding studies
have demonstrated highly similar binding specificities, although c-Rel homodimers appear
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to bind a broader range of κB site sequences than RelA13. We observed highly correlated
binding of c-Rel and RelA homodimers over our large set of ~3,300 κB sites (Figs. 1,3 and
Supplementary Fig. 2). Despite these similarities, c-Rel and RelA can elicit distinct
biological functions in vivo6,17. c-Rel homodimers can preferentially activate the mouse
Il12b gene by binding non-traditional NF-κB sites with much higher affinity than RelA
homodimers17. Forty-six amino acids within the c-Rel RHR were found to be responsible
for the enhanced binding affinity, and a chimeric RelA protein containing these 46 residues
rescued Il12b expression in cRel−/− macrophages.
To determine the relationship between our PBM profiles and binding affinity, SPR was
performed with six different DNA sequences. For all sequences tested, except for one that
bound poorly to both dimers, we observed much slower dissociation rates (Koff) for c-Rel
homodimers than for RelA homodimers (Table 1). Importantly, swapping these 46 residues
of the c-Rel RHR domain into RelA (protein RelA/N3,4) led to substantially slower
dissociation rates (Table 1). RelA/N3,4 homodimers also exhibited a binding specificity that
correlated more closely with c-Rel homodimers (Pearson r = 0.87) than with RelA
homodimers (Pearson r = 0.82) (Fig. 4). However, these specificity differences are subtle in
comparison to the global difference in binding affinity distinguishing c-Rel from RelA
homodimers (median fold difference of 8.7 for c-Rel, RelA Koff values). Thus, while the
DNA-binding specificities of RelA and c-Rel homodimers are highly correlated, c-Rel
homodimers have much slower off-rates than RelA homodimers, resulting in a higher
overall affinity and contributing to the selective regulation of c-Rel-dependent genes.
These results raised the question of whether binding affinities might discriminate other NF-
κB dimers with correlated binding specificities. We performed SPR experiments with the
six different DNA sequences using mouse p50:p50 homodimers and c-Rel:p50, RelA:p50,
RelB:p50 and RelB:p52 heterodimers (Supplementary Table 1). The results failed to reveal
differences of the same magnitude as those found for c-Rel and RelA homodimers. The most
notable difference was that c-Rel:p50 heterodimers exhibited slower off-rates with some
DNA sequences than the other heterodimers. Although the magnitudes of these differences
were smaller than those observed with c-Rel and RelA homodimers (median Koff fold
difference of 8.7 for the c-Rel, RelA homodimer, versus pairwise heterodimer differences
ranging from 1.1 to 5.0), the results raise the possibility that enhanced binding affinity
allows c-Rel:p50 heterodimers to selectively regulate some genes.
Comparison with in vivo binding data
We examined the relationship between our PBM-derived binding data and available
genome-scale ChIP datasets on in vivo occupancy of RelA and p5031-33. We found highly
significant enrichment for high-scoring PBM-determined κB site sequences within ChIP-
enriched (i.e., dimer-bound) regions (Supplementary Fig. 7). Moreover, we found significant
enrichment when traditional κB sites were masked from the genomic sequence. These
results demonstrate that both traditional and non-traditional κB sites in our PBM dataset
represent binding sequences utilized in vivo.
To determine whether PBM-determined dimer-specific differences correlate with dimer-
specific binding differences in vivo, we examined an NF-κB ChIP dataset33 in which ChIP-
chip was performed on LPS-stimulated human macrophages for all five NF-κB proteins.
Focusing on p50 binding, which had the largest number of bound regions, we separated
regions into those bound by p50 only (regions bound by p50:p50 homodimers, Fig. 5a) and
those also bound by at least one of RelA, c-Rel or RelB (regions bound by p50 heterodimers
or multiple dimers, Fig. 5a). This analysis allowed us to examine whether particular κB
sequences distinguish regions bound only by p50:p50 homodimers and whether our PBM
data for different dimers capture these sequence differences.
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The ~8,000 human promoter regions in the ChIP dataset33 were scanned with our PBM-
determined 12-bp κB site sequences and assigned the z-score of the top-scoring κB site (see
Supplementary Methods). Receiver-operating-characteristic (ROC) curve analyses were
performed to quantify whether the p50-bound regions (true positives) scored more highly
than the unbound regions (true negatives). We observed strong area under the ROC curve
(AUC) enrichment scores for all three dimers tested (Fig. 5b-d). However, strikingly, we
observed that p50:p50 PBM data yielded significantly higher enrichment scores for the
regions bound only by p50 than for the regions bound by additional NF-κB members
(AUC=0.84 versus 0.67, Fig. 5b). This was not the case for the RelA PBM data, which
showed no discrimination between the two types of regions (Fig. 5d). This demonstrates that
κB sequence features can discriminate the p50-specifically bound regions, and that these
features correlate best with p50:p50 homodimer PBM data. The same analysis performed
with PBM-determined 10-bp or 11-bp κB sites did not show the same discriminatory
capacity for p50:p50 (data not shown) suggesting that the p50-bound sites are discriminated
primarily by p50:p50 preferences for 12-bp long κB sites. These results demonstrate that the
PBM-derived, dimer-specific binding differences relate directly to dimer-specific binding
differences in vivo.
Discussion
A complete understanding of NF-κB dimer DNA-binding specificities and affinities will
provide critical insight into mechanisms available for dimer-specific function in the cell. In
this study, we examined the DNA-binding preferences of ten NF-κB dimers from mouse and
human to a wide-ranging set of 3,285 potential κB site sequences. We anticipate that this
large and detailed dataset of κB sites will prove useful for analyses of NF-κB regulatory
elements at a genome scale.
Our results have immediate biological and mechanistic implications for each of the three
dimer classes (Table 2). For the c-Rel and RelA homodimers, one major finding is that c-Rel
homodimers bind with substantially higher affinity than RelA homodimers to all kB sites,
despite highly correlated binding profiles. This suggests an affinity-dependent mechanism
for discriminating these homodimers where c-Rel homodimers out-compete RelA
homodimers for κB sites in vivo on the basis of DNA binding affinity. Under these
conditions, RelA homodimers will not preferentially bind to any κB sites. Therefore, to
selectively regulate genes in cells that also express c-Rel homodimers (primarily
hematopoietic cells), RelA homodimers need to rely on mechanisms other than selective
DNA-binding, such as RelA-dependent co-activator interactions34,35.
For the heterodimer class, the most important biological and mechanistic implication of our
results is that the selective functions of each heterodimer may not be achieved via dimer-
specific recognition of κB motifs in target genes. The PBM data for all heterodimers
correlated closely, indicating that they recognize the same sequences. It is especially
noteworthy that binding data for RelB:p52 correlated closely with those of the other
heterodimers. It has been reported that RelB:p52, but not RelB:p50 and RelA:p50, can bind
well to the non-traditional murine BLC-kB site16. More recently, it was reported that
RelB:p52 is less discriminatory than RelA:p50 and can bind to a broader set of κB site
sequences20. Binding sites unique to RelB:p52 – the primary dimer activated in response to
the alternative NF-κB pathway18,19 – would provide a mechanism for cells to differentiate
target genes of the alternative NF-κB pathway from those of the classical pathway activating
RelA:p506.
However, additional studies report that RelB:p52 and RelA:p50 share highly similar binding
specificities, with no clear preference exhibited by RelB:p5221. We found that RelB:p52 and
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RelB:p50 do not differ significantly in their DNA-binding preferences (see Supplementary
Discussion). Furthermore, we now extend this to include all NF-κB heterodimers,
demonstrating that NF-κB heterodimers exhibit common binding preferences to the ~3,300
κB site sequences examined in this study. Modest binding differences reported for
heterodimers20 may be below the resolution of our approach and may prove functionally
important in vivo and will need to be examined in greater depth in the future. However, this
work and others21 suggest that the regulation of distinct sets of genes by different
heterodimers is likely achieved primarily through alternative mechanisms, such as dimer-
specific interactions with co-regulatory proteins34, dimer-specific synergy with other
transcription factors, or dimer-specific conformational differences20,36,37.
For the p50 and p52 homodimers, we defined a subset of κB site sequences bound
preferentially by these homodimers. Importantly, these sequences include a novel G-rich
p50 homodimer recognition motif found upstream of the IFN-inducible Gbp1 gene (5′-
GGGGGAAAAA-3′, p50:p50 z-score = 6.2; c-Rel:c-Rel z-score = 4.5) shown to mediate
p50 homodimer-dependent repression38. This suggests that many other non-traditional, G-
rich p50:p50-preferred κB sites in our dataset may similarly function as p50:p50-specific
target sites in vivo.
In addition to the broad principles summarized above, our results highlight additional levels
of complexity in NF-κB-DNA interactions. First, we observed that DNA binding site motifs
for significantly bound sites exhibited one strong half-site but a degenerate preference for
the opposing half-site (Fig. 2). This is in contrast to more symmetric motifs derived from the
highest affinity κB sites (Fig. 1). Second, we observed that non-traditional κB sites appear
to be shorter (8- to 9-bp long) than traditional κB sites (9- to 11-bp long). These findings
suggest a more modest requirement for a κB site: one traditional half-site sequence
recognized via a stereotyped pattern of amino acid-base contacts, with a second half-site that
can exhibit considerable plasticity. These results are consistent with structural analyses
showing considerable plasticity in both the global conformation of the protein-DNA
complex and the amino acid-base contacts mediated by the dimer subunits12,28,39. Analyses
of c-Rel and RelA homodimers bound to different κB sequences revealed stereotyped amino
acid-base interactions with the consensus 5′-GGAA-3′ half-site common to each structure,
but highly variable contacts with the half-site sequences that differed between the structures.
We propose that structural plasticity afforded by the ability of NF-κB dimers to bind to
many κB sites with only a single strong half-site provides a mechanism to partially
disentangle DNA binding from structural conformation. In turn, this may allow increased
structural diversity and the potential for allosteric mechanisms in transcriptional control as
have been reported in several cases36,37.
In addition to highlighting the challenge of understanding how DNA sequence may
influence NF-kB conformation and the functional consequences of NF-kB binding, our
results emphasize the importance of the relationship between binding specificity, affinity
and function. Our dataset reveals NF-κB binding to a remarkably diverse range of
sequences, and suggests that many functionally important sequences (e.g., the Il2 CD28 RE)
may diverge considerably from the optimal κB site. Furthermore, we observed highly
overlapping binding specificity of NF-kB dimers and considerable potential for competitive
binding. It is well established that, in reporter assays, high-affinity binding sites for NF-κB
and other factors lead to stronger transcription than low-affinity sites40. However, in a
physiological setting within the context of native chromatin, it is not known whether an
affinity threshold must be achieved for function, whether a simple relationship exists
between affinity and transcriptional output, or what role the effects of co-regulatory proteins
and other DNA-bound transcription factors will play. The results reported here provide a
further step toward addressing these fundamental questions. Unlike basic consensus
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sequences and PWMs, which reveal preferences at each position of a recognition motif, data
provided by PBMs and other high-throughput methods41,42 reveal preferences throughout
the continuum of possible binding sequences. These datasets will be invaluable for detailed
analyses of the DNA sequence-dependence of transcriptional regulatory control.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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APPENDIX
Methods
Preparation of protein samples
Mouse sequences for RelA, c-Rel, p50, p52, and RelB were cloned into a modified pET11a
expression vector for purification. Constructs contained the Rel-homology region (RHR) of
each subunit: RelA (1-314 a.a.), c-Rel (1-282 a.a.), p50 (1-429 a.a.), RelB (1-400 a.a.). The
p50 subunit had a C-terminal FLAG tag. Proteins were expressed in BL21 (DE3)
Escherichia coli cells (0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) induction) for
16 h at 25°C. Heterodimer subunits were co-expressed using a bicistronic expression
plasmid43. Protein purification was performed on a Q-Sepharose High Performance anion
exchange column (GE Healthcare) and a SP Sepharose High Performance cation exchange
column (GE Healthcare) and analyzed by SDS-PAGE and EMSA. The final purified protein
samples were then frozen in aliquots in a storage buffer of 50 mM Tris-HCl, pH 8.0 150 mM
NaCl, 5 mM DTT, and 10% glycerol.
Expression constructs for the human NF-κB dimers were created as established
previously44. Briefly, histidine-tagged recombinant proteins were produced using pET
vectors in BL21 (DE3) E. coli (Merck). Constructs contained the Rel-homology region
(RHR) of each subunit: RelA (1-307 a.a.), c-Rel (1-285 a.a.), p50 (7-356 a.a.), p52 (4-332
a.a.) RelB (120-401 a.a.). Proteins expressed was induced with 0.2 mM isopropyl β-D-1-
thiogalactopyranoside (IPTG) at 30 °C for 5 h. Cell pellets were harvested in “Ni-NTA
Binding” buffer with added EDTA-free Protease Inhibitor (Roche), pulse-sonicated for 2
min and debris removed via centrifugation at 16,000 g. A two-step purification procedure
was then employed, first with the “Ni-NTA His-Bind Resin” system (Merck #70666) and
then a subsequent purification based on DNA-affinity isolation of functional, DNA-binding
protein. Ni-NTA purification was carried according to manufacturer’s guidelines while for
DNA-affinity isolation, the processing of a sample derived from 250 ml of bacterial culture
required 0.128 μM of the oligonucleotides “TNF-promoter” (biotinylated) and “TNF-
promoter complementary”. Oligonucleotides were annealed via incubation in NEB Buffer 3
(New England Biolabs) at 94°C for 1 min, followed by 69 cycles of 1 min with step-wise
decrease of 1°C. 712.5 μl of pre-annealed oligonucleotide mixture was conjugated with
streptavidin-agarose (Sigma).
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PBM experiments and analysis
PBM experiments were performed using custom-designed oligonucleotide arrays (Agilent
Technologies, Inc.,) Two different PBM designs were used: all 10-bp site universal PBM
(Agilent Technologies Inc., AMADID #016060, 4×4K array format) described previously26,
and a custom NF-κB PBM developed as part of this study (AMADID #025227, Agilent
Technologies, Inc.) DNA probe sequences synthesized on the custom-designed arrays are
provided (Supplementary File 1).
Custom-designed oligonucleotide arrays (Agilent Technologies, Inc.) were converted to
double-stranded DNA arrays by primer extension and used in PBM experiments as
described previously22,26. Protein samples were incubated on the microarrays
(concentrations provided, Supplementary Table 2 and 3), for 1 h in binding buffer (10 mM
Tris-HCl, pH 7.4; 0.2 μg/μl bovine serum albumin (BSA) (New England BioLabs
#B9001S); 0.3 ng/μl salmon testes DNA (Sigma, #D7656); 2% non-fat dry milk (Stop &
Shop brand); 0.02% Triton X-100; 3 mM dithiothreitol (DTT); NaCl or KCl (salt
concentrations provided, Supplementary Table 2 and 3). Protein-bound arrays were then
washed and incubated with primary antibody (see Supplementary Tables 2 and 3, column 4)
for 20 min. For PBM experiments in which a secondary antibody was used (see
Supplementary Tables 2 and 3, column 4) we deviated from the published protocol22 and
applied an additional wash step (0.05% Tween-20/PBS for 3 min; 0.01% Triton X-100 for 2
min) before 20 min secondary antibody incubation (Supplementary Table 2 and 3, column
5).
Microarray scanning, quantification, and data normalization were performed using GenePix
Pro ver. 6 (Axon) and masliner (MicroArray LINEar Regression) software as previously
described22,26. For the custom NF-κB PBM, median fluorescence intensities for each 10-bp
κB site were determined from the eight corresponding probes (forward and reverse
complement orientations, four replicates each, Fig. 1a). For each PBM experiment, the
median fluorescence intensity (MI) for each of the 3,285 10-bp κB sites was transformed
into a z-score using the mean (u) and standard deviation (SD) derived from the median
intensities values of a background set of 1,200 randomly selected 10-bp sequences also
present on the PBM; i.e., z-score = (MI − u)/SD.
Surface Plasmon Resonance (SPR) experiments
Sensorgrams were recorded on a Biacore T100 (GE Healthcare) using streptavidin chips
(Sensor Chip SA). Biotinylated oligonucleotide probes were immobilized on the surface of
the streptavidin sensor chip in running buffer (10 mM HEPES, pH 7.5 150 mM NaCl, 3 mM
EDTA, 0.005% Tween 20). Protein samples were applied to the sensor chip at 50 μL/min, at
10°C and referenced to an unmodified surface. Binding data was collected in the running
buffer described above; sensor chip surface was regenerated with a 90 second pulse of 2 M
NaCl followed by 180 second pulse of the running buffer. Dissociation rates were obtained
by global fitting of the real-time kinetic data using the Scrubber2 software (BioLogic
Software) and a simple 1:1 binding model. Six concentrations of each NF-κB protein were
used, ranging from 1 nM to 1 μM.
Comparison and clustering of NF-κB PBM data
NF-κB dimer binding specificities was compared using the Pearson correlation coefficient
of κB site z-scores.. Only κB sites with a z-score > 1 in at least one experiment were
included in these calculations. Further, possibly redundant κB sites were ignored in the
calculation if they could be explained by a higher-scoring κB site (i.e., if a higher-scoring
κB 10-bp site matched its probe sequence); ~500 κB sites met this criteria. Calculations
were performed using the R statistical software package. Hierarchical clustering and
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visualization of the comparison matrix (Fig. 1c) were performed using the heatmap function
in R, with a ‘euclidean’ distance function and a ‘complete’ clustering function.
DNA binding site motif analysis
Binding motifs for universal PBM experiments were derived using the Seed-and-Wobble
algorithm22,26. DNA binding site motifs from top-scoring κB sites identified by custom NF-
κB PBM experiments were determined by running the Priority 2.1.0 motif finding
algorithm45 on the 10-bp sequences. Graphical sequence logos were generated using
enoLOGOS46.
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Figure 1.
Examining NF-κB dimer binding by custom NF-κB PBMs. (a) Schematic of design of 60
base-pair (bp) DNA sequence probes on custom NF-κB PBM. 10-bp κB sites are positioned
at a fixed position along the probe (i.e., relative to the glass slide surface) within constant
flanking sequence. Each 10-bp κB site is present at four replicate spots in both the forward
(‘Probe’) and reverse complement (‘RC Probe’) orientation (i.e., eight spots in total). (b)
Distributions of PBM-derived binding site z-scores for mouse RelA:p50 binding to 3,285
κB sites (black line) and to a background set of 1,200 random 10-bp sequences (blue line).
Z-scores for 15 κB sites described in the literature are indicated. (c) Pair-wise comparison of
κB site binding for 10 NF-κB dimers. Pair-wise binding similarity was assessed by Pearson
correlation of κB site z-scores, and hierarchical clustering was performed on the comparison
matrix (see Methods). Three DNA-binding specificity clusters (i.e., class) were identified
that correspond to three NF-κB dimer groups: p50,p52 homodimers, heterodimers and c-
Rel,RelA homodimers. Representative DNA binding site motifs were determined for each
dimer class using the top 25 highest-scoring κB sites bound by each group member
(Methods; see Supplementary Fig. 2 for individual motifs).
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Figure 2.
Dimer-specific binding to traditional and non-traditional κB sites. (a) Comparison of the
binding by mouse p50:p50 and c-Rel:c-Rel homodimers to 3,285 κB sites (black dots) and a
background set of 1,200 random 10-bp sites (blue dots). κB sites conforming to the patterns
5′-GGGGGNNNNN-3′ (N = any base) and 5′-HGGAANNNNND-3′ (H = not G, D = not
C, NNNNN = all 5-bp sequences except those containing CCC triplets) are highlighted in
yellow and red, respectively. Binding motifs specific for subsets of κB sites are shown. (b)
Z-scores and DNA sequences of six κB sites used in subsequent SPR experiments (see (c)
and (d) below and Table 1) are shown. (c),(d) Comparison of SPR-determined binding off-
rates (Koff) and PBM-determined z-scores are shown for c-Rel:c-Rel and p50:p50
homodimers, respectively.
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Figure 3.
Preferences for flanking DNA bases and κB site length. (a) Z-score distributions are shown
for 10-bp κB sites with different flanking bases (e.g. identity of N and M in
NGGGAATCCCCM). In each panel, column 1 has scores for κB sites with no 5′ guanine
(forward orientation, N = not G; reverse complement orientation, M = not C); column 2 has
scores for κB sites with 5′ guanine (N = G); column 3 has scores for κB sites with 5′
guanine in reverse complement orientation (M = C). κB sites for which a 5′ guanine
flanking base (column 2 or 3) results in significantly higher z-scores (p-value < 0.01, one-
tailed Student’s t-test) are indicated (10−4 (***), 10−3 (**), 10−2 (*)). Data are shown for
PBM experiments performed for p50:p50, RelA:p50 and c-Rel:c-Rel. (b) Z-score
distributions are shown for the non-traditional 10-bp κB site 5′-GGGGAATTTT-3′ and
shorter variant sites. Score distribution for 10-bp sites are as in (a). Score distributions for
shorter sites are determined by examining scores from all κB sites in our dataset that
contained the sub-site sequence. For example, column 2 labeled xGGGAATTTT has scores
from the 4 κB sites where x = A,C,G or T.
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Figure 4.
Comparison of c-Rel, RelA and RelA/N3,4 homodimer DNA-binding specificity. (a)
Comparison of the binding by mouse c-Rel:c-Rel and RelA:RelA homodimers to 3,285 κB
sites (black dots) and a background set of 1,200 random 10-bp sites (blue dots). (b)
Comparison for c-Rel:c-Rel and RelA/N3,4:RelA/N3,4. (c) Comparison for RelA/
N3,4:RelA/N3,4 and RelA:RelA. (d) Comparison for RelA:RelA (replicate experiment) and
RelA:RelA.
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Figure 5.
Enrichment of PBM-determined κB sites in published dataset of p50-bound genomic
regions from LPS-stimulated human macrophages33. (a) Venn diagram showing the overlap
of 183 p50-bound regions with the 205 regions bound by c-Rel, RelB or RelA. Bound
regions are the ChIP enriched regions (p-value < 0.002) reported in Figure 1 of Schreiber et
al. (b,c,d) Receiver operating characteristic (ROC) curve analyses quantifying the
enrichment within p50-bound regions of PBM-determined κB sites are shown for (b) p50,
(c) RelA:p50, and (d) RelA. ROC curves describe enrichment within p50-specifically bound
regions (blue line), and within regions bound by p50 and at least one of cRel, RelB, or RelA
(black line). Area under the ROC curve (AUC) values are reported to quantify the
enrichment, and a Wilcox-Mann-Whitney U test was applied to calculate the significance of
each AUC value.
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Table 2
Principles of regulatory specificity for NF-κB dimer classes.
c-Rel:c-Rel, RelA:RelA Homodimers
Highly correlated binding profiles
Selective activation by c-Rel:c-Rel achieved via enhanced binding affinity17
Selective activation by RelA:RelA may require interactions with co-regulatory proteins34
Heterodimers
Highly correlated binding profiles
Selective activation by each heterodimer may require interactions with co-regulatory proteins
p50:p50, p52:p52 Homodimers
Highly correlated binding profiles
Non-traditional, G-rich sites support preferential binding by these dimers and confer dimer-
specific regulatory functions38
All dimers
Binding to varied DNA sites (e.g. different lengths, one degenerate half-site) that correlates
with structural differences of DNA-bound complexes may facilitate allosteric regulatory
mechanisms36,37
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